Annual ROA
-275.54%
-112.64%-69.15%
December 31, 2022
Summary
- As of February 8, 2025, NAVB annual return on assets is -275.54%, with the most recent change of -112.64% (-69.15%) on December 31, 2022.
- During the last 3 years, NAVB annual ROA has fallen by -79.55% (-40.59%).
- NAVB annual ROA is now -161.11% below its all-time high of 450.90%, reached on December 31, 2017.
Performance
NAVB ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-22.89%
+64.49%+73.80%
September 30, 2023
Summary
- As of February 8, 2025, NAVB quarterly return on assets is -22.89%, with the most recent change of +64.49% (+73.80%) on September 30, 2023.
- Over the past year, NAVB quarterly ROA has increased by +64.49% (+73.80%).
- NAVB quarterly ROA is now -104.74% below its all-time high of 483.34%, reached on March 31, 2017.
Performance
NAVB Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
NAVB ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -69.2% | +73.8% |
| 3 y3 years | -40.6% | +73.8% |
| 5 y5 years | -161.1% | +73.8% |
NAVB ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -69.2% | at low | at high | +93.5% |
| 5 y | 5-year | -69.2% | at low | at high | +93.5% |
| alltime | all time | -161.1% | +45.2% | -104.7% | +97.2% |
Navidea Biopharmaceuticals ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -22.89%(-73.8%) |
| Jun 2023 | - | -87.38%(-75.2%) |
| Mar 2023 | - | -352.65%(+8.7%) |
| Dec 2022 | -275.54%(+69.1%) | -324.57%(+18.3%) |
| Sep 2022 | - | -274.36%(+49.9%) |
| Jun 2022 | - | -183.03%(+26.4%) |
| Mar 2022 | - | -144.85%(+10.4%) |
| Dec 2021 | -162.90%(-9.5%) | -131.16%(+6.0%) |
| Sep 2021 | - | -123.68%(-8.1%) |
| Jun 2021 | - | -134.58%(-13.5%) |
| Mar 2021 | - | -155.51%(-14.5%) |
| Dec 2020 | -180.06%(-8.1%) | -181.79%(-9.5%) |
| Sep 2020 | - | -200.93%(+6.3%) |
| Jun 2020 | - | -189.03%(-10.4%) |
| Mar 2020 | - | -210.87%(+12.0%) |
| Dec 2019 | -195.99%(+69.1%) | -188.22%(+13.0%) |
| Sep 2019 | - | -166.51%(+4.4%) |
| Jun 2019 | - | -159.50%(+29.9%) |
| Mar 2019 | - | -122.78%(-2.6%) |
| Dec 2018 | -115.92%(-125.7%) | -126.10%(+17.8%) |
| Sep 2018 | - | -107.02%(+41.3%) |
| Jun 2018 | - | -75.72%(+5.1%) |
| Mar 2018 | - | -72.07%(-122.1%) |
| Dec 2017 | 450.90%(-532.1%) | 326.77%(-8.6%) |
| Sep 2017 | - | 357.44%(-14.8%) |
| Jun 2017 | - | 419.33%(-13.2%) |
| Mar 2017 | - | 483.34%(-502.5%) |
| Dec 2016 | -104.34%(-49.3%) | -120.07%(+19.9%) |
| Sep 2016 | - | -100.12%(-27.7%) |
| Jun 2016 | - | -138.52%(-10.0%) |
| Mar 2016 | - | -153.88%(-13.6%) |
| Dec 2015 | -205.73%(+50.1%) | -178.07%(-10.7%) |
| Sep 2015 | - | -199.31%(+11.7%) |
| Jun 2015 | - | -178.39%(+10.2%) |
| Mar 2015 | - | -161.86%(+14.2%) |
| Dec 2014 | -137.02%(-16.1%) | -141.75%(+9.2%) |
| Sep 2014 | - | -129.82%(-1.9%) |
| Jun 2014 | - | -132.38%(-5.8%) |
| Mar 2014 | - | -140.50%(-3.3%) |
| Dec 2013 | -163.32%(+20.9%) | -145.29%(-3.4%) |
| Sep 2013 | - | -150.46%(-20.0%) |
| Jun 2013 | - | -188.08%(+7.0%) |
| Mar 2013 | - | -175.80%(+22.4%) |
| Dec 2012 | -135.09%(-606.1%) | -143.61%(+19.6%) |
| Sep 2012 | - | -120.12%(+4763.2%) |
| Jun 2012 | - | -2.47%(-118.7%) |
| Mar 2012 | - | 13.23%(-52.3%) |
| Dec 2011 | 26.69%(-105.3%) | 27.71%(-61.7%) |
| Sep 2011 | - | 72.44%(-167.7%) |
| Jun 2011 | - | -107.03%(-79.9%) |
| Mar 2011 | - | -531.17%(-6.4%) |
| Dec 2010 | -502.65%(+18.3%) | -567.47%(-0.2%) |
| Sep 2010 | - | -568.78%(-30.1%) |
| Jun 2010 | - | -813.90%(+69.7%) |
| Mar 2010 | - | -479.71%(+9.1%) |
| Dec 2009 | -425.02%(+586.2%) | -439.59%(-5.9%) |
| Sep 2009 | - | -467.30%(+128.6%) |
| Jun 2009 | - | -204.40%(+402.1%) |
| Mar 2009 | - | -40.71%(-38.8%) |
| Dec 2008 | -61.94% | -66.49%(-19.6%) |
| Sep 2008 | - | -82.71%(+15.1%) |
| Jun 2008 | - | -71.84%(-6.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | -77.19%(+3.4%) |
| Dec 2007 | -67.41%(+39.4%) | -74.64%(+17.5%) |
| Sep 2007 | - | -63.51%(-5.1%) |
| Jun 2007 | - | -66.90%(+17.7%) |
| Mar 2007 | - | -56.86%(+15.2%) |
| Dec 2006 | -48.37%(+32.2%) | -49.36%(+8.8%) |
| Sep 2006 | - | -45.37%(+19.7%) |
| Jun 2006 | - | -37.89%(-2.0%) |
| Mar 2006 | - | -38.65%(+6.0%) |
| Dec 2005 | -36.60%(+17.6%) | -36.45%(-21.1%) |
| Sep 2005 | - | -46.21%(+14.2%) |
| Jun 2005 | - | -40.47%(+13.0%) |
| Mar 2005 | - | -35.80%(-3.1%) |
| Dec 2004 | -31.13%(+25.2%) | -36.96%(+57.2%) |
| Sep 2004 | - | -23.51%(-20.8%) |
| Jun 2004 | - | -29.70%(+12.1%) |
| Mar 2004 | - | -26.49%(+1.2%) |
| Dec 2003 | -24.87%(-22.8%) | -26.18%(+37.7%) |
| Sep 2003 | - | -19.01%(-16.4%) |
| Jun 2003 | - | -22.73%(-25.1%) |
| Mar 2003 | - | -30.35%(-2.3%) |
| Dec 2002 | -32.20%(<-9900.0%) | -31.08%(-12.6%) |
| Sep 2002 | - | -35.58%(+67.4%) |
| Jun 2002 | - | -21.26%(+101.5%) |
| Mar 2002 | - | -10.55%(-5961.1%) |
| Dec 2001 | 0.16%(-99.2%) | 0.18%(-99.1%) |
| Sep 2001 | - | 19.22%(-8.2%) |
| Jun 2001 | - | 20.93%(-24.8%) |
| Mar 2001 | - | 27.82%(+15.4%) |
| Dec 2000 | 20.56%(-155.0%) | 24.10%(-823.7%) |
| Sep 2000 | - | -3.33%(-84.7%) |
| Jun 2000 | - | -21.70%(-78.1%) |
| Mar 2000 | - | -99.08%(-5.3%) |
| Dec 1999 | -37.41%(-64.3%) | - |
| Jun 1999 | - | -104.65%(+6.8%) |
| Mar 1999 | - | -97.95%(-0.0%) |
| Dec 1998 | -104.66%(+137.4%) | -97.97%(+47.3%) |
| Sep 1998 | - | -66.51%(+17.3%) |
| Jun 1998 | - | -56.69%(+4.9%) |
| Mar 1998 | - | -54.06%(+23.3%) |
| Dec 1997 | -44.08%(-7.6%) | -43.83%(-7.4%) |
| Sep 1997 | - | -47.35%(+6.8%) |
| Jun 1997 | - | -44.35%(+0.7%) |
| Mar 1997 | - | -44.02%(-8.8%) |
| Dec 1996 | -47.73%(+6.5%) | -48.25%(+10.4%) |
| Sep 1996 | - | -43.71%(-9.7%) |
| Jun 1996 | - | -48.42%(-18.5%) |
| Mar 1996 | - | -59.38%(+11.2%) |
| Dec 1995 | -44.81%(-23.9%) | -53.41%(-9.6%) |
| Sep 1995 | - | -59.06%(-23.3%) |
| Jun 1995 | - | -76.98%(-6.0%) |
| Mar 1995 | - | -81.92%(+1.5%) |
| Dec 1994 | -58.86%(-5.8%) | -80.69%(-21.6%) |
| Sep 1994 | - | -102.97%(+10.7%) |
| Jun 1994 | - | -93.00%(+6.2%) |
| Mar 1994 | - | -87.57%(+20.9%) |
| Dec 1993 | -62.50%(+212.5%) | -72.46%(+10.4%) |
| Sep 1993 | - | -65.63%(+30.3%) |
| Jun 1993 | - | -50.38%(+67.9%) |
| Mar 1993 | - | -30.00%(+62.3%) |
| Dec 1992 | -20.00% | -18.48%(+10.9%) |
| Sep 1992 | - | -16.67% |
FAQ
- What is Navidea Biopharmaceuticals annual return on assets?
- What is the all time high annual ROA for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals annual ROA year-on-year change?
- What is Navidea Biopharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly ROA year-on-year change?
What is Navidea Biopharmaceuticals annual return on assets?
The current annual ROA of NAVB is -275.54%
What is the all time high annual ROA for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual return on assets is 450.90%
What is Navidea Biopharmaceuticals annual ROA year-on-year change?
Over the past year, NAVB annual return on assets has changed by -112.64% (-69.15%)
What is Navidea Biopharmaceuticals quarterly return on assets?
The current quarterly ROA of NAVB is -22.89%
What is the all time high quarterly ROA for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly return on assets is 483.34%
What is Navidea Biopharmaceuticals quarterly ROA year-on-year change?
Over the past year, NAVB quarterly return on assets has changed by +64.49% (+73.80%)